Myocardial infarction associated with dextrofenfluramine.
出版信息
BMJ. 1990 Nov 3;301(6759):1049-50. doi: 10.1136/bmj.301.6759.1049-d.
Abstract
摘要
相似文献
1
Myocardial infarction associated with dextrofenfluramine.与右芬氟拉明相关的心肌梗死
BMJ. 1990 Nov 3;301(6759):1049-50. doi: 10.1136/bmj.301.6759.1049-d.
2
Efficacy and safety of dexfenfluramine in obese patients: a multicenter study.
Clin Neuropharmacol. 1988;11 Suppl 1:S173-8.
3
Myocardial infarction associated with the use of dextrofenfluramine.与使用右芬氟拉明相关的心肌梗死
BMJ. 1990 Aug 11;301(6747):345. doi: 10.1136/bmj.301.6747.345-b.
4
The fenfluramine/phentermine combination for weight loss.用于减肥的芬氟拉明/苯丁胺组合。
Nurse Pract. 1997 Aug;22(8):166, 168, 170.
5
Fenfluramine and mental retardation.芬氟拉明与智力迟钝
J Am Acad Child Adolesc Psychiatry. 1991 May;30(3):507-8. doi: 10.1097/00004583-199105000-00027.
6
Fenfluramine treatment in female rats accelerates the weight loss associated with activity-based anorexia.对雌性大鼠进行芬氟拉明治疗可加速与基于活动的厌食症相关的体重减轻。
Pharmacol Biochem Behav. 2005 Feb;80(2):273-9. doi: 10.1016/j.pbb.2004.11.006. Epub 2004 Dec 19.
7
Effect of 6 months therapy with dexfenfluramine in obese patients: studies in the United Kingdom.
Clin Neuropharmacol. 1988;11 Suppl 1:S179-86.
8
Plasma fenfluramine levels, weight loss, and side effects.血浆芬氟拉明水平、体重减轻及副作用。
Br Med J. 1977 Nov 19;2(6098):1322-5. doi: 10.1136/bmj.2.6098.1322.
9
[Drug therapy of obesity--results of treatment with dexfenfluramine].[肥胖症的药物治疗——右芬氟拉明的治疗结果]
Med Pregl. 1990;43(5-6):232-5.
10
Factors that may effect the reduction of hunger and body weight following d-fenfluramine administration.服用右旋芬氟拉明后可能影响饥饿感减轻和体重下降的因素。
Clin Neuropharmacol. 1988;11 Suppl 1:S160-72.
本文引用的文献
1
Microdiets: love them or leave them?
Br Med J (Clin Res Ed). 1987 Jun 20;294(6587):1565. doi: 10.1136/bmj.294.6587.1565.
2
International trial of long-term dexfenfluramine in obesity.
Lancet. 1989 Nov 11;2(8672):1142-5. doi: 10.1016/s0140-6736(89)91499-2.
3
Myocardial infarction associated with the use of dextrofenfluramine.与使用右芬氟拉明相关的心肌梗死
BMJ. 1990 Aug 11;301(6747):345. doi: 10.1136/bmj.301.6747.345-b.
4
Oral-contraceptive use in relation to myocardial infarction.
Lancet. 1979 Apr 7;1(8119):743-7. doi: 10.1016/s0140-6736(79)91205-4.
Zotero 插件